Skip to main navigation Skip to search Skip to main content

Therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplantation in lymphoma patients

  • Mojtaba Akhtari
  • , Vijaya Raj Bhatt
  • , Pavan Kumar Tandra
  • , Jairam Krishnamurthy
  • , Heidi Horstman
  • , Amy Dreessen
  • , Pei Xian Chen
  • , James O. Armitage

Research output: Contribution to journalReview articlepeer-review

Abstract

AML, acute myeloid leukemia; ASCT, autologous hematopoietic stem cell transplantation; t-MN, therapy-related myeloid neoplasm; PBPC, peripheral blood progenitor cells; TBI, total body irradiation; XRCC1, X-ray repair cross-complementing 1; FISH, fluorescent in-situ hybridization, GVHD, graft-versus-host-disease; MDS, myelodysplastic syndrome; MTHFR, methylenetetrahydrofolate reductase, GSTM1, glutathione S-transferase mu 1; PTPRT, protein tyrosine phosphatase, receptor type; P72R, proline 72 arginine; BEAM, BCNU, etoposide, Ara-C and melphalan; NHL, non-Hodgkin lymphoma; MOPP, mechlorethamine, chlorambucil, cyclophosphamide, and lomustine; HL, Hodgkin lymphoma; NA, not available.

Original languageEnglish
Pages (from-to)1077-1088
Number of pages12
JournalCancer Biology and Therapy
Volume14
Issue number12
DOIs
StatePublished - Dec 2013

ASJC Scopus Subject Areas

  • Molecular Medicine
  • Oncology
  • Pharmacology
  • Cancer Research

Keywords

  • Acute myeloid leukemiautologous hematopoietic stem cell transplantation
  • Hodgkin lymphoma
  • Myelodysplasia
  • Non-Hodgkin lymphoma
  • Therapy-related myeloid neoplasms

Cite this